These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21790007)

  • 1. [Expression of GSK3B gene in peripheral blood in patient with Parkinson's disease].
    Filatova EV; Shadrina MI; Karabanov AV; Slominskiĭ PA; Illarioshkin SN; Ivanova-Smolenskaia IA; Limborskaia SA
    Mol Biol (Mosk); 2011; 45(3):459-63. PubMed ID: 21790007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression analysis of suppression of tumorigenicity 13 gene in patients with Parkinson's disease.
    Shadrina MI; Filatova EV; Karabanov AV; Slominsky PA; Illarioshkin SN; Ivanova-Smolenskaya IA; Limborska SA
    Neurosci Lett; 2010 Apr; 473(3):257-9. PubMed ID: 20193743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAPT rs242562 and GSK3B rs334558 are associated with Parkinson's Disease in central China.
    Yu L; Huang J; Zhai D; Liu L; Guo K; Long X; Xiong J; Zhang Z; Wang Y; Zhao Y; Wu P; Wang D; Lin Z; Wu J; Xiong N; Wang T
    BMC Neurosci; 2014 Apr; 15():54. PubMed ID: 24779391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSK3B polymorphisms alter transcription and splicing in Parkinson's disease.
    Kwok JB; Hallupp M; Loy CT; Chan DK; Woo J; Mellick GD; Buchanan DD; Silburn PA; Halliday GM; Schofield PR
    Ann Neurol; 2005 Dec; 58(6):829-39. PubMed ID: 16315267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study.
    Wider C; Vilariño-Güell C; Heckman MG; Jasinska-Myga B; Ortolaza-Soto AI; Diehl NN; Crook JE; Cobb SA; Bacon JA; Aasly JO; Gibson JM; Lynch T; Uitti RJ; Wszolek ZK; Farrer MJ; Ross OA
    Eur J Neurol; 2011 Jun; 18(6):876-81. PubMed ID: 21159074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.
    Kettunen P; Larsson S; Holmgren S; Olsson S; Minthon L; Zetterberg H; Blennow K; Nilsson S; Sjölander A
    J Alzheimers Dis; 2015; 44(4):1313-22. PubMed ID: 25420549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The relationship between glycogen synthase kinase-3 beta (GSK3B) -50T/C -1727A/T polymorphisms and alcoholism].
    Yoshihara E; Aoki J; Kurihara K; Numajiri M; Iwahashi K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2011 Dec; 46(6):570-5. PubMed ID: 22413565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of tau kinases (CDK5R1 and GSK3B) in Parkinson's disease: a study from India.
    Das G; Misra AK; Das SK; Ray K; Ray J
    Neurobiol Aging; 2012 Jul; 33(7):1485.e9-15. PubMed ID: 21130530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase-3 beta and tau genes interact in Parkinson's and Alzheimer's diseases.
    García-Gorostiaga I; Sánchez-Juan P; Mateo I; Rodríguez-Rodríguez E; Sánchez-Quintana C; del Olmo SC; Vázquez-Higuera JL; Berciano J; Combarros O; Infante J
    Ann Neurol; 2009 Jun; 65(6):759-61; author reply 761-2. PubMed ID: 19557862
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson's disease.
    DeMarshall CA; Han M; Nagele EP; Sarkar A; Acharya NK; Godsey G; Goldwaser EL; Kosciuk M; Thayasivam U; Belinka B; Nagele RG;
    Immunol Lett; 2015 Nov; 168(1):80-8. PubMed ID: 26386375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Found in transcription: accurate Parkinson's disease classification in peripheral blood.
    Karlsson MK; Sharma P; Aasly J; Toft M; Skogar O; Sæbø S; Lönneborg A
    J Parkinsons Dis; 2013; 3(1):19-29. PubMed ID: 23938308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of two oxidative stress-related genes (heme oxygenase-1 and GSK3β) on the risk of Parkinson's disease.
    Infante J; García-Gorostiaga I; Sánchez-Juan P; Sierra M; Martín-Gurpegui JL; Terrazas J; Mateo I; Rodríguez-Rodríguez E; Berciano J; Combarros O
    Eur J Neurol; 2010 May; 17(5):760-2. PubMed ID: 20039940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic Profiling of Exosomal Proteins for Blood-based Biomarkers in Parkinson's Disease.
    Kitamura Y; Kojima M; Kurosawa T; Sasaki R; Ichihara S; Hiraku Y; Tomimoto H; Murata M; Oikawa S
    Neuroscience; 2018 Nov; 392():121-128. PubMed ID: 30266682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analysis raises candidate genes in blood for early screening of Parkinson's disease.
    Zhang Y; Yao L; Liu W; Li W; Tian C; Wang ZY; Liu D
    Biomed Environ Sci; 2014 Jun; 27(6):462-5. PubMed ID: 24961856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upgraded Methodology for the Development of Early Diagnosis of Parkinson's Disease Based on Searching Blood Markers in Patients and Experimental Models.
    Kim A; Nigmatullina R; Zalyalova Z; Soshnikova N; Krasnov A; Vorobyeva N; Georgieva S; Kudrin V; Narkevich V; Ugrumov M
    Mol Neurobiol; 2019 May; 56(5):3437-3450. PubMed ID: 30128652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VCP expression decrease as a biomarker of preclinical and early clinical stages of Parkinson's disease.
    Alieva A; Rudenok M; Filatova E; Karabanov A; Doronina O; Doronina K; Kolacheva A; Ugrumov M; Illarioshkin S; Slominsky P; Shadrina M
    Sci Rep; 2020 Jan; 10(1):827. PubMed ID: 31964996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in Parkinson's disease (recent update).
    Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
    Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular signature in blood identifies early Parkinson's disease.
    Molochnikov L; Rabey JM; Dobronevsky E; Bonucelli U; Ceravolo R; Frosini D; Grünblatt E; Riederer P; Jacob C; Aharon-Peretz J; Bashenko Y; Youdim MB; Mandel SA
    Mol Neurodegener; 2012 May; 7():26. PubMed ID: 22651796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of α-synuclein gene in Parkinson's disease in North Karnataka, India.
    Kadakol GS; Kulkarni SS; Wali GM; Gai PB
    Neurol India; 2014; 62(2):149-52. PubMed ID: 24823723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression.
    Joaquim HP; Talib LL; Forlenza OV; Diniz BS; Gattaz WF
    J Psychiatr Res; 2012 Aug; 46(8):1053-8. PubMed ID: 22622071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.